Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 128–128 | Cite as

Ibrutinib

Pneumonia: case report
Case report
  • 13 Downloads

Reference

  1. Iskierka-Jazdzewska E, et al. Ibrutinib discontinuation in patients with relapsed or refractory chronic lymphocytic leukemia treated in a compassionate use program: A report from the Polish Adult Leukemia Study Group (PALG). Advances in Clinical and Experimental Medicine 28: 1051-1057, No. 8, Aug 2019. Available from: URL: http://doi.org/10.17219/acem/99911 - PolandCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations